Population
Patients with cardiac light-chain (AL) amyloidosis
Design
Review
Key result
Cardiac involvement affects 70% to 80% of patients with AL amyloidosis and represents the leading cause of mortality, making early diagnosis and multidisciplinary management critical.
Authors
Loading...
Urges early cardiac assessment in AL amyloidosis; leaves open optimal strategies pending higher-level evidence.
Early diagnosis and intervention with chemo-immunotherapy or autologous stem cell transplantation are critical for improving outcomes in cardiac AL amyloidosis.
Moaddab et al. (2026) conducted a review in Cardiac light-chain (AL) amyloidosis. Cardiac involvement affects 70% to 80% of patients with AL amyloidosis and represents the leading cause of mortality, making early diagnosis and multidisciplinary management critical.